|Bid||1.7600 x 3100|
|Ask||1.8000 x 3100|
|Day's range||1.6800 - 1.8900|
|52-week range||0.9800 - 9.7500|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||N/A|
|Earnings date||09 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||8.63|
Shares of Cano Health (NYSE: CANO) fell 27.9% in December, according to data provided by S&P Global Market Intelligence. The company provides health and dental care management, with pharmacy services, home visits, telehealth, wellness activities, and transition care, mainly to Medicare Advantage members.
Shares of Cano Health (NYSE: CANO) were down as much as 35.6% this week and were still down 31.2% for the week as of late Thursday afternoon, according to data from S&P Global Intelligence. The stock fell even further after investment advisor Third Point, run by Dan Loeb, worried about Cano's liquidity, sold its remaining 3.5% stake in the company, according to a Bloomberg report. Cano, as of the third quarter, reported only $24 million in cash and cash equivalents.
What happened Cano Health (NYSE: CANO) saw its shares drop 46.9% last month. The company operates primary care and connected medical practices for seniors in Florida, Texas, Nevada and Puerto Rico. The company's stock closed October at $3.